Protagenic Therapeutics Statistics
Total Valuation
PTIX has a market cap or net worth of 2.15 million. The enterprise value is 1.59 million.
| Market Cap | 2.15M |
| Enterprise Value | 1.59M |
Important Dates
The next estimated earnings date is Thursday, November 19, 2026.
| Earnings Date | Nov 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PTIX has 1.81 million shares outstanding. The number of shares has decreased by -62.49% in one year.
| Current Share Class | 1.81M |
| Shares Outstanding | 1.81M |
| Shares Change (YoY) | -62.49% |
| Shares Change (QoQ) | -4.06% |
| Owned by Insiders (%) | 4.99% |
| Owned by Institutions (%) | 4.59% |
| Float | 1.72M |
Valuation Ratios
The trailing PE ratio is 0.40.
| PE Ratio | 0.40 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.25 |
| P/TBV Ratio | 1.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.29 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.66
| Current Ratio | 0.66 |
| Quick Ratio | 0.53 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.39 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -57.31% |
| Return on Invested Capital (ROIC) | -301.90% |
| Return on Capital Employed (ROCE) | -246.99% |
| Weighted Average Cost of Capital (WACC) | 6.32% |
| Revenue Per Employee | n/a |
| Profits Per Employee | 2.73M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.94% in the last 52 weeks. The beta is 0.38, so PTIX's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -66.94% |
| 50-Day Moving Average | 0.45 |
| 200-Day Moving Average | 0.97 |
| Relative Strength Index (RSI) | 76.62 |
| Average Volume (20 Days) | 28,780 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.68 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -4.26M |
| Pretax Income | 5.46M |
| Net Income | 5.46M |
| EBITDA | -4.21M |
| EBIT | -4.26M |
| Earnings Per Share (EPS) | 2.94 |
Balance Sheet
The company has 565,985 in cash and no debt, with a net cash position of 565,985 or 0.31 per share.
| Cash & Cash Equivalents | 565,985 |
| Total Debt | n/a |
| Net Cash | 565,985 |
| Net Cash Per Share | 0.31 |
| Equity (Book Value) | 1.72M |
| Book Value Per Share | 0.95 |
| Working Capital | -362,743 |
Cash Flow
In the last 12 months, operating cash flow was -2.00 million and capital expenditures -3,297, giving a free cash flow of -2.00 million.
| Operating Cash Flow | -2.00M |
| Capital Expenditures | -3,297 |
| Depreciation & Amortization | 44,956 |
| Net Borrowing | -1.13M |
| Free Cash Flow | -2.00M |
| FCF Per Share | -1.11 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PTIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 62.49% |
| Shareholder Yield | 62.49% |
| Earnings Yield | 253.55% |
| FCF Yield | -93.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |